About Us

Home > About Histogen > News and Events

Latest News

Histogen Creates PUR Biologics, a Joint Venture Developing Next-Generation, Biologic Solutions in Orthopedic Applications

Histogen Announces Initial Results from Phase I/II Clinical Trial of HSC

U.S. Patent issued for Histogen's Novel Cell Growth Process

Histogen Signs License Agreement with Suneva Medical for Cell Conditioned Media-based Aesthetic Products

More >>  


Upcoming Events

National Procedures Institute - Cosmetic and Anti-Aging Medicine
April 25 - 26, 2013
Charlston, SC
Dr. Gail Naughton to speak on the topic of Stem Cell Research and Technology in Cosmetic Dermatology.

National Institute of Health (NIH) Biotechnology Training Program
April 26, 2013
Washington State University
Dr. Gail Naughton to present.

International Investigative Dermatology Annual Meeting
May 8 - 11, 2013
Edinburgh, Scotland
Histogen to present "Embryonic-like cell-secreted proteins induce hair growth in a phase I/II trial in male pattern baldness".

World Summit on Regenerative Medicine
October 23 - 26, 2013
Xi'an, China
Dr. Gail Naughton to present.

Bio2Device Group Meeting
November 12, 2013
Palo Alto, CA
Dr. Gail Naughton to present "Aesthetics: A Novel Business Model for Regenerative Medicine"

Histogen's proprietary tissue-engineering process is utilized for manufacturing all of Histogen's products. Newborn cells are placed into a bioreactor and conditioned with a liquid media.
  • HSC's components have recently been shown to be critical for new hair follicle formation
  • The field of stem cell research is rapidly expanding
  • Histogen scientists have developed regenerative medical technologies without the use of stem cells or animal serum
© Histogen Inc., CA 92121